Cigna Q2 2025 adj. EPS $7.20 beats prior year; revenue $67.2B; reaffirms FY adj. EPS $29.60+

Cigna Group

2025-Q2 EPS reported $10.55 vs consensus $7.37 ▲ beat (+43.2%)

Shareholders' net income of $1.5B ($5.71 diluted EPS); adjusted income from operations $1.9B ($7.20 per share), up 7% YoY.
Evernorth Health Services adjusted revenues up 17% to $57.8B; adjusted income up 5% to $1.70B pre-tax.
Cigna Healthcare adjusted revenues down 18% to $10.8B due to HCSC divestiture; MCR 83.2% vs 82.3% YoY.
Total medical customers 18.0M, down 6% from Dec 2024 reflecting HCSC sale; pharmacy customers up 3% to 121.9M.
2025 outlook reaffirmed: consolidated adj. EPS at least $29.60; Evernorth adj. income $7.2B; Cigna Healthcare adj. income $4.125B.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.